Dimethyl fumarate
Dimethyl Fumarate is a prescription medication used to treat relapsing forms of multiple sclerosis. It comes as delayed-release capsules in 120 mg and 240 mg strengths, taken orally. Manufactured by Mylan Pharmaceuticals Inc. under ANDA210531. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dimethyl Fumarate is a prescription medication used to treat relapsing forms of multiple sclerosis. It comes as delayed-release capsules in 120 mg and 240 mg strengths, taken orally. Manufactured by Mylan Pharmaceuticals Inc. under ANDA210531. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dimethyl fumarate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dimethyl fumarate — ANDA 210305 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210305"
}
]
|
| identifier | ANDA210305 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"fda",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dimethyl fumarate |
